BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-138210 | Pharmaceuticals
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Bone Morphogenetic Proteins Industry Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET
7.1 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEINS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Sigma-Aldrich Co
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Smith & Nephew Inc
16.3 Orthofix Holdings Inc
16.4 Nuvasive Inc
16.5 Musculoskeletal Transplant Foundation
16.6 Medtronic
16.7 Stryker Corporation
16.8 DePuy Synthes
16.9 Cellumed Co Ltd
16.10 ProSpec-Tany TechnoGene Ltd
16.11 Zimmer Biomet Holdings Inc
16.12 Wright Medical Group NV
16.13 Xtant Medical Holdings Inc
16.14 Ember Therapeutics
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2
Recombinant Human Bone Morphogenetic Protein (rhBMP) -7
Market by Application :
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-maxillofacial
Companies
Sigma-Aldrich Co
Smith & Nephew Inc
Orthofix Holdings Inc
Nuvasive Inc
Musculoskeletal Transplant Foundation
Medtronic
Stryker Corporation
DePuy Synthes
Cellumed Co Ltd
ProSpec-Tany TechnoGene Ltd
Zimmer Biomet Holdings Inc
Wright Medical Group NV
Xtant Medical Holdings Inc
Ember Therapeutics
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.